BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 3032938)

  • 41. Phosphorothioate analogues of 5-phosphoribosyl 1-diphosphate: synthesis, purification, and partial characterization.
    Smithers GW; O'Sullivan WJ
    Biochemistry; 1984 Sep; 23(20):4767-73. PubMed ID: 6208937
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Folate-deficient human lymphoblasts: changes in de novo purine and pyrimidine synthesis and phosphoribosylpyrophosphate.
    van Der Weyden MB; Rose IS; Newitt P
    Eur J Haematol; 1991 Sep; 47(3):213-8. PubMed ID: 1717312
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The rate of purine synthesis de nova in blood mononuclear cells in vitro from patients with familial hyperuricaemic nephropathy.
    MacDermot KD; Allsop J; Watts RW
    Clin Sci (Lond); 1984 Aug; 67(2):249-58. PubMed ID: 6744792
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Some regulatory properties of purine biosynthesis de novo in long-term cultures of epithelial-like rat liver cells.
    Bashkin P; Sperling O
    Biochim Biophys Acta; 1978 Feb; 538(3):505-11. PubMed ID: 626753
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Overproduction disease in man due to enzyme feedback resistance mutation. Purine overproduction in gout due to excessive activity of mutant feedback-resistant phosphoribosylpyrophosphate synthetase.
    Sperling O; Boer P; Brosh S; Zoref E; de Vries A
    Enzyme; 1978; 23(1):1-9. PubMed ID: 203449
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Lesch-Nyhan syndrome: the synthesis of inosine 5'-phosphate in the hypoxanthine-guanine phosphoribosyltransferase-deficient erythrocyte by alternate biochemical pathways.
    Lowy BA; Williams MK
    Pediatr Res; 1977 May; 11(5):691-4. PubMed ID: 870876
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Increased de novo purine synthesis in cultured skin fibroblasts from heterozygotes for the Lesch-Nyhan syndrome. A sensitive marker for carrier detection.
    Zoref E; Sperling O
    Hum Hered; 1979; 29(1):64-8. PubMed ID: 761926
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dependence of the metabolic fate of IMP on the rate of total IMP synthesis. Studies in cultured fibroblasts from normal subjects and from purine-overproducing mutant patients.
    Zoref-Shani E; Sperling O
    Biochim Biophys Acta; 1980 May; 607(3):503-11. PubMed ID: 6249370
    [No Abstract]   [Full Text] [Related]  

  • 49. Effect of lowered intracellular ATP and GTP concentrations on purine ribonucleotide synthesis and interconversion.
    Barankiewicz J; Henderson JF
    Can J Biochem; 1977 Mar; 55(3):257-62. PubMed ID: 195682
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Recent advances in the identification of enzyme abnormalities underlying excessive purine synthesis in man.
    Becker MA; Seegmiller JE
    Arthritis Rheum; 1975; 18(6 Suppl):687-94. PubMed ID: 173346
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A comparison of purine metabolism and nucleotide pools in normal and hypoxanthine-guanine phosphoribosyltransferase-deficient neuroblastoma cells.
    Snyder FF; Cruikshank MK; Seegmiller JE
    Biochim Biophys Acta; 1978 Nov; 543(4):556-69. PubMed ID: 718989
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Regulation of de novo purine biosynthesis in normal and 8-azaguanine-resistant Chinese hamster cells.
    Taylor MW; Tokito MK; Gupta KC; Pipkorn J
    Biochim Biophys Acta; 1978 Jan; 517(1):1-13. PubMed ID: 203317
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Enzymic capacities of purine de Novo and salvage pathways for nucleotide synthesis in normal and neoplastic tissues.
    Natsumeda Y; Prajda N; Donohue JP; Glover JL; Weber G
    Cancer Res; 1984 Jun; 44(6):2475-9. PubMed ID: 6327016
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Purine metabolic cycle in normal and leukemic leukocytes.
    Dietz AA; Czebotar V
    Cancer Res; 1977 Feb; 37(2):419-26. PubMed ID: 188545
    [TBL] [Abstract][Full Text] [Related]  

  • 55. PRPP synthetase superactivity in lymphoblast lines.
    Becker MA; Losman MJ; Rimon D; Kim M
    Adv Exp Med Biol; 1986; 195 Pt A():51-8. PubMed ID: 3014839
    [No Abstract]   [Full Text] [Related]  

  • 56. Human phosphoribosylpyrophosphate synthetase: radioimmunochemical quantitation in erythrocytes and fibroblasts.
    Itkin P; Woo S; Becker MA
    J Lab Clin Med; 1984 Jul; 104(1):96-109. PubMed ID: 6330252
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The influence of ribose 5-phosphate availability on purine synthesis of cultured human lymphoblasts and mitogen-stimulated lymphocytes.
    Pilz RB; Willis RC; Boss GR
    J Biol Chem; 1984 Mar; 259(5):2927-35. PubMed ID: 6699001
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Purine metabolism in normal and thioguanine-resistant neuroblastoma.
    Wood AW; Becker MA; Minna JD; Seegmiller JE
    Proc Natl Acad Sci U S A; 1973 Dec; 70(12):3880-3. PubMed ID: 4521214
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Abnormal purine metabolism and purine overproduction in a patient deficient in purine nucleoside phosphorylase.
    Cohen A; Doyle D; Martin DW; Ammann AJ
    N Engl J Med; 1976 Dec; 295(26):1449-54. PubMed ID: 825775
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Purine metabolism in Toxoplasma gondii.
    Krug EC; Marr JJ; Berens RL
    J Biol Chem; 1989 Jun; 264(18):10601-7. PubMed ID: 2732241
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.